Topical composition comprising transformed bacteria expressing a compound of interest
First Claim
1. A method of providing protection to human skin from UVA and UVB radiation, from 280-400 nm, by topically applying to the skin non-pathogenic, Gram-positive bacteria that has been genetically modified to express a mycosporine-like amino acid (MAA), wherein the method comprises the steps of(a) transforming non-pathogenic, Gram-positive bacteria selected from the group consisting of Lactobacillus lactis and Lactococcus lactis with a vector comprising a sequence encoding shinorine;
- (b) expressing shinorine at a level of about 0.1 mM to about 100 mM for 102-1020 cfu of the transformed bacteria, and(c) topically applying to the skin of a human in need of protection from UVA and UVB radiation at least 102 cfu/cm2 of the transformed bacteria from step (a).
1 Assignment
0 Petitions
Accused Products
Abstract
Compositions comprised of a population of transformed bacteria formulated for topical application to a subject are described. The population of transformed bacteria are created from a non-pathogenic bacteria and transformed to express a compound of interest for a therapeutic or a cosmetic purpose. In one embodiment, the composition is for protection of the skin from ultraviolet rays.
-
Citations
11 Claims
-
1. A method of providing protection to human skin from UVA and UVB radiation, from 280-400 nm, by topically applying to the skin non-pathogenic, Gram-positive bacteria that has been genetically modified to express a mycosporine-like amino acid (MAA), wherein the method comprises the steps of
(a) transforming non-pathogenic, Gram-positive bacteria selected from the group consisting of Lactobacillus lactis and Lactococcus lactis with a vector comprising a sequence encoding shinorine; -
(b) expressing shinorine at a level of about 0.1 mM to about 100 mM for 102-1020 cfu of the transformed bacteria, and (c) topically applying to the skin of a human in need of protection from UVA and UVB radiation at least 102 cfu/cm2 of the transformed bacteria from step (a). - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
Specification